Herpes simplex virus (HSV-1 and HSV-2)

Herpes is a lifelong infection, which often has mild or no symptoms but can be detected by the presence of antibodies in the blood.

More than 3.7 billion people worldwide under the age of 50 are infected with herpes simplex virus type 1 (HSV-1), while an estimated 417 million people aged 15-49 have HSV-2 infection.1

Determining the type of HSV a person is infected with has an important impact on patient management and treatment decisions—HSV-2 recurrence is considerably higher than that of HSV-1. Molecular testing by PCR is the most sensitive method of direct detection for the herpes simplex virus.

Roche Molecular tests enable highly sensitive, specific detection and differentiation of two separate regions on each of the HSV-1 and HSV-2 genomes, providing accurate detection of the virus and peace of mind when managing patients.

Reference:

  1. World Health Organization (WHO). Herpes simplex virus. http://www.who.int/mediacentre/factsheets/fs400/en/. Accessed May 13, 2016.